baber/WOPTO huggingface dataset:
Patent NZ-200396-A (NZ)
Title: Push button actuator plate for placement over and protection of a push button keyboard
Inventor: RUZIC H
IPC: H01H13/70
Filed: 1982-04-23
Abstract: 1. Telephone set with a pushbutton dialling keypad whose keytops (3) have hat-shaped cross sections, are guided in a cover (2) and are each, with the aid of a flexible member (4; 9), connected to a plunger (5; 10) serving to actuate the contacts (7; 11), characterized in that said cover (2) is placed on to a guide plate (1) having upright tubular extensions (6) which are overlapped by said keytops (3) and in which said plungers (5; 10) are guided, and that said guide plate (1), said cover (2) and said keytops (3) are all made of metal.
Patent NZ-206690-A (NZ)
Title: Phenolic resin laminates
Inventor: COUSIN M
IPC: C08J7/046
Filed: 1983-12-22
Abstract: Reinforced phenolic laminates are provided with a finishing coat of a butylated phenol-formaldehyde resin, thereby removing surface irregularities. The finishing coat can be mass-pigmented to the desired color, thereby obviating the necessity of any additional color-containing coatings.
Patent NZ-216872-A (NZ)
Title: 1-carba(1-dethia)-3-cephem-4-carboxylic acid derivatives as antibiotics
Inventor: EVANS D A
IPC: A61K31/435
Filed: 1986-07-16
Abstract: 7β-Acylamino-3-trifluoromethylsulfonyloxy-1-carba-3-cephem-4-carboxylic acid antibitic compounds, esters and salts thereof, and the corresponding 7-amino and protected 7-amino 1-carbacephalosporins are provided. The 3-trifluoromethylsulfonyloxy-substituted 1-carbacephalosporins also are useful in a process for preparing 3-halo-1-carbacephalosporins which comprises displacing the 3-trifluoromethylsulfonyloxy ester group with halide ion in an aprotic polar solvent.
Patent NZ-222368-A (NZ)
Title: Preparation of polyethylene articles of high tensile strength, high modulus and low creep from polyethylene having 2-20 alkyl side chains per 1000 carbon atoms
Inventor: BASTIAANSEN CORNELIUS WILHELMU
IPC: C08L23/04
Filed: 1987-10-30
Abstract: Polyethylene articles having a high tensile strength above 2.0 GPa, a modulus above 70 GPa and a creep below 3 x 10<-><7> sec<-><1> are obtained via thermoreversible gelation of a solution of polyethylene with a Mv above 5 x 10<5> kg/kmole, followed by ultradrawing. As polyethylene a copolymer or a blend is used containing 2-20 lower alkyl side chains per 1000 carbon atoms.
Patent NZ-226645-A (NZ)
Title: Method of treating birds with antibiotic ll-e19020#a# and ll-e19020b
Inventor: CARTER GUY THOMAS
IPC: A61K35/66
Filed: 1988-10-20
Abstract: This invention provides a method for treating chronic respiratory disease, fowl cholera and necrotic enteritis in infected birds, by orally administering thereto a pharmaceutically effective amount of antibiotic LL-E19020 alpha , antibiotic LL-E19020 beta  or a physiologically acceptable salt thereof. The physico-chemical characteristics of LL-E19020 alpha  are as follows: Approximate elemental analysis : C 62.73; H 7.60; N1.00; 0 28.67 (by difference);  Molecular weight: 1225 (FABMS);  Apparent molecular formula: C65H95NO21;  Specific rotation: [ alpha ]26_D = O (C 0.385, methanol);   LL-E19020 beta Approximate elemental analysis: C 63.33; H 7.72; N 1.16; 0 27.79 (by difference);  Molecular weight: 1225 (FABMS);  Apparent molecular formula:  C65H95NO21; Specific rotation: [ alpha ]26_D = -17+/-2(C 0.455, methanol);
Patent NZ-230700-A (NZ)
Title: Use of l-threonic, l-xylonic and l-lyxonic acids and derivatives for increasing therapeutic effectiveness of pharmaceutical compositions
Inventor: MARKHAM RICHARD G
IPC: A61P3/00
Filed: 1989-09-19
Abstract: A therapeutic compsn. comprises: (a) a therapeutically active cpd. having (i) a mol.wt. below 5000, (ii) an acidic-functional gp. and a pKa of equal to or less than 6 at the physiological pH of 7.4, and (iii) which is normally eliminated unmetablised via the renal tubular secretion pathway for organic anions; and (b) at least one cpd. selected from the gp. consisting of L-threonic, L-xylonic and L-lyxonic acids and their edible non-toxic salts, aldonolactones and aldono lactides. Also claimed is a Vitamin C compsn., a method of establishing high vitamin C levels, a method of suppressing the excretion of organic anions, and a method of improving the absorption of organic anions in body tissue.
Patent NZ-234085-A (NZ)
Title: Immunogen comprising a residue of a histamine-releasing peptide together with an antibody-eliciting residue and ligands thereof
Inventor: STANWORTH DENIS RAYMOND
IPC: C07K16/00
Filed: 1990-06-15
Abstract: An immunogen comprising a residue of a histamine-releasing peptide comprising a cationic N-terminal head and a hydrophobic C-terminal tail, together with a residue capable of eliciting antibodies against said peptide whilst inhibiting histamine release by said peptide is useful in anti-allergy treatment. Preferably the histamine-releasing peptide is of formula:  Lys-Thr-Lys-Gly-Ser-Gly-Phe-Phe-Val-Phe,  optionally amidated at the C terminal. Antibodies to the histamine-releasing peptide are useful for passive immunisation.
Patent NZ-237394-A (NZ)
Title: Pharmaceutical germicidal composition comprising an aqueous solution of iodine, at least one organic substance which reacts with iodine and a source of iodate ions
Inventor: BUXTON IAN RICHARD
IPC: A61P31/04
Filed: 1991-03-12
Abstract: A pharmaceutical composition comprising an aqueous solution of elemental iodine and at least one organic substance which reacts with iodine, whereby iodine loss is controlled by providing a source of iodate loss sufficient to provide from 0.01% to 0.04% by weight iodate ions, preferably from 0.02% to 0.03% by weight iodate ions. <IMAGE>
Patent NZ-243632-A (NZ)
Title: Absorbent structure with a fluid distribution well
Inventor: LEVESQUE YVON
IPC: A61F13/45
Filed: 1992-07-20
Abstract: A composite absorbent structure capable of extremely short fluid penetration time, well-suited for use as an absorbent core in disposable absorbent products such as adult disposable briefs, diapers, incontinence pads, sanitary napkins, wound dressings and bandages. The composite absorbent structure (16) comprises a highly absorbent fluid transfer sheet (18) having a low fluid retentiveness, and a laminated, wicking reservoir (20) with a high fluid retentiveness in intimate fluid communication with the fluid transfer sheet to draw fluid therefrom under the effect of capillary action. The laminated reservoir includes superposed layers (22,24), the layer closest to the fluid transfer sheet being provided with a fluid distribution well (26). A highly porous and hydrophilic spacer element (27) is inserted between the reservoir layers establishing a high void volume area which forms an extension of the fluid absorptive well between the reservoir layers. The invention also comprehends a method for providing a rapid fluid absorption in a disposable absorbent product. <IMAGE>
Patent NZ-275646-A (NZ)
Title: Tricyclic sulphonamide derivatives and medicaments
Inventor: BISHOP W ROBERT
IPC: C07D409/14
Filed: 1994-10-12
Abstract: A method of inhibiting Ras function and therefore inhibiting cellular growth is disclosed. The method comprises the administration of a compound containing a tricyclic ring system to a biological system. In particular, the method inhibits cellular growth in a mammal such as a human being. Novel compounds of formula (4.0) are disclosed. Also disclosed are processes for making 3-substituted compounds of formula (4.0). Further disclosed are novel compounds which are intermediates in the processes for making the 3-substituted compounds of formula (4.0).
Patent NZ-278930-A (NZ)
Title: Expressing heterologous proteins in attenuated bacteria using htra promoters
Inventor: KHAN MOHAMMED ANJAM
IPC: C12N15/09
Filed: 1995-01-31
Abstract: The invention provides a DNA construct comprising the <u>htrA</u> promoter sequence operably linked to a DNA sequence encoding one or more heterologous proteins, replicable expression vectors containing the constructs, and attenuated bacteria containing the constructs or vectors. The invention also provides a vaccine composition comprising an attenuated bacterium as defined above, or a fusion protein expressed from a construct as defined above, and a pharmaceutically acceptable carrier.
Patent NZ-312536-A (NZ)
Title: Swimming pool surface cleaner apparatus comprises a unitary heavier-than-water body, a level control subsystem and means for supplying a fluid flow
Inventor: HENKIN MELVYN L
IPC: E04H4/16
Filed: 1996-06-26
Abstract: Automatic swimming pool cleaning method and apparatus for cleaning a water pool (1) contained in an open vessel (2) defined by a containment wall (3) having a bottom (4) and side (5) portions utilizing a unitary structure or body (6) configured for immersion in a pool (1) for selective operation proximate the water surface (7) in a surface cleaning mode or proximate to the interior wall surface portions (8) in a wall surface cleaning mode.
Patent NZ-326527-A (NZ)
Title: Novel paclitaxel analogs, specifically 2', 3' side-chain halogenated cephalomannines that show strong efficacy in a variety of tumors
Inventor: PANDEY RAMESH C
IPC: A61K31/335
Filed: 1996-12-13
Abstract: The present invention relates to Paclitaxel analogs like 2", 3" side chain halogenated cephalomannines specifically 2", 3" -dihalocephalomannine and 2",3"dihalo-7-epicephalomannine. These have the following formula 1 where R is selected from Figures 1a-1d X is halogen. These compounds are used for treating tumors, also claimed is the process for preparing these.
Patent NZ-334980-A (NZ)
Title: Aminomethylene derivatives with ultraviolet absorption capability
Inventor: HUKUOKA NAOHIKO
IPC: C07D239/60
Filed: 1997-10-03
Abstract: An aminomethylene derivative represented by the formula I.  Wherein;  A is a cyclic oxo group selected from the formula (a), (b), (c), (d), and (e); wherein R1, R2, R3, R4 and R5 each independently represent H, an alkyl group, cycloalkyl groups, aralkyl groups and aryl groups; R6, R7 and R8 each independently represent an alkyl group alkyl group, cycloalkyl groups, aralkyl groups and aryl groups; R1 and R2 or R7 and R8 may combine with each other to form a tetramethylene group;  R represents an alkyl group optionally containing OH or O; and n is an integer of 0-4.  The derivatives have excellent ultraviolet absorption ability and a high optical stability. The derivatives are useful for as ultraviolet absorbents such as cosmetic sunscreens, or as part of weather proofing material.
Patent NZ-337579-A (NZ)
Title: Anti-convulsant isoquinolyl-benzamide derivatives such as 5-amino-2-benzyl-1-methyl-1,2-dihydroisoquinoline for use and pharmaceutical composition
Inventor: HARLING JOHN DAVID
IPC: A61P21/00
Filed: 1998-03-16
Abstract: A carboxamide derivative of the Formula (I) useful in the treatment and/prevention of anxiety, mania, depression, panic disorders and/or aggression, disorders associated with subarachnoid haemorrhage or neural shock, the effects associated with withdrawal from substances of abuse such as cocaine, nicotine, alcohol and benzadiazepines, disorders treatable and/or preventable with anti-convulsive agents, such as epilepsy including post traumatic epilepsy, Parkinson's disease, psychosis, migraine, cerebral ischaemia, Alzheimer's disease and other degenerative diseases such as Huntington's chorea, schizophrenia, obsessive compulsive disorders, neurological deficits associated with AIDS, sleep disorders (including circadian rhythm disorders, insomnia and narcolepsy), tics (e.g. Giles de la Tourette's syndrome), traumatic brain injury, tinnitus, neuralgia, especially trigeminal neuralgia, neuropathic pain, dental pain, cancer pain, inappropriate neuronal activity resulting in neurodysthesias in diseases such as diabetes, multiple sclerosis (MS) and motor neuron disease, ataxias, muscular rigidity (spasticity), temporomandibular joint dysfunction and amyotrophic lateral sclerosis (ALS). The processes for making compounds of Formula (I) are described. Wherein; R1 is hydrogen, C1-6alkyl (optionally substituted by hydroxy or C1-4alkoxy), C1-6alkenyl, C1-6alkynyl, C1-6alkyICO-, formyl, CF3CO- or C1-6alkyISO2-; R2 is hydrogen or up to three substituents selected from halogen, NO2, CN, N3, CF3O-, CF3S-, CF3CO-, trifluoromethyldiazirinyl, C1-6alkyl, C1-6alkenyl, C1-6alkynyl, C1-6perfluoroalkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl-, C1-6alkyIO-, C1-6alkyICO-, C3-6cycloalkyI0-, C3-6cycloalkyICO-, C3-6cycloalkylC l-4alkyl 0-, C 3-6cycloalkyl-C1-4alkyICO-, phenyl, phenoxy, benzyloxy, benzoyl, phenyl-C1-4alkyl-, C1-6alkyIS-, C1-6alkylSO2-, (C1-4alkyl)2NSO2-, (C1-4alkyl)NHSO2-, (C1-4alkyl)2NCO-, (C1-4alkyl)NHCO- or CONH2; or -NR5R6 where R5 is hydrogen or C1-4alkyl, and R6 is hydrogen, C1-4alkyl, formyl, -CO2C1-4alkyl or -COC1-4alkyl; or two R -groups together form a carbocyclic ring that is saturated or unsaturated and un-substituted or substituted by -OH or =O; and the two R3 groups and the two R4 groups are each independently hydrogen or C1-6alkyl or the two R3 groups and/or the two R4 groups together form a C3-6spiroalkyl group provided that at least one R3 or R4 group is not hydrogen; provided that the compound is not 1-methyl-6-benzoylamino-l,2,3,4tetrahydroisoquinoline, or 1,2-dimethyl-6-benzoylamino-1,2,3,4tetrahydroisoquinoline.
Patent NZ-502391-A (NZ)
Title: Mammalian cytokine: interleukin-B30 and related reagents
Inventor: BAZAN J FERNANDO
IPC: C12Q1/68
Filed: 1998-07-24
Abstract: Purified genes encoding cytokine from a mammal, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding this molecule are provided. Methods of using said reagents and diagnostic kits are also provided. An isolated or recombinant polynucleotide encoding an antigenic polypeptide comprising: (a) At least 17 contiguous amino acids from the mature coding portion of SEQ ID NO: 2; (b) At least 17 contiguous amino acids from the mature coding portion of SEQ ID NO: 4; or (c) At least 17 contiguous amino acids from the mature coding portion of SEQ ID NO: 5.
Patent NZ-503881-A (NZ)
Title: Floor mat
Inventor: BROCK THOMAS ALBERT PATRICK
IPC: A47L23/22
Filed: 1998-09-10
Abstract: There is provided a mat having multiple sets of pins, each set of pins being located within a surrounding, characterized in that the pins do not extend significantly beyond the highest point of the surrounding. Thus the pins are protected by the surrounding and are less likely to break after extended use. The mat may be provided with areas adapted for the receipt (of strips of textile materials, e.g. carpeting which advantageously has a hard-backing and is able to snap into the areas provided. The inclusion of the textile material combines a scraping function together with the visual appearance of a carpet. The strips of textile material will be separated by sets of pins as described above. A set of such mats is also described
Patent NZ-508161-A (NZ)
Title: Low smoke, low toxicity carpet
Inventor: MAPLES DENNIS
IPC: C09K21/14
Filed: 1999-04-14
Abstract: A fire resistant carpet backing formulation has five components of: (a) a polyurethane dispersion; (b) fire retardant components having at least a) ammonium polyphosphate, b) melamine, and c) a char former; (c) solvents including water; (d) filler, pigment and grinding aids; and (e) surfactants. Preferred char formers are pentaerythritol and polysaccharides. The polyurethane dispersion is present in about 18-30 % by weight, the fire retardant components of part (b) are present in about 39-61 % by weight and the solvents of part (c) are present in about 9-25 % by weight in the preferred embodiments. Nylon carpets made with this backing are fire retardant and meet the airline standards for fire safety.
Patent NZ-511156-A (NZ)
Title: Spectacles, typically sports glasses, with brow frame moulded in two-shot process with hard outer layer and soft inner layer
Inventor: CANAVAN RICHARD W
IPC: G02C5/16
Filed: 2001-04-18
Abstract: The unitary structure consists of a soft inner portion to engage to the brow and nose of a wearer and a hard outer portion adapted to support a transparent lens portion. Temple pieces are formed by a two-shot process in a single mould that chemically bonds the soft portion to the hard portion.
Patent NZ-511349-A (NZ)
Title: Pyrazolopyridine derivatives useful as selective COX-2 inhibitors
Inventor: CAMPBELL IAN BAXTER
IPC: A61P5/00
Filed: 1999-11-01
Abstract: A pyrazolo[1,5-a]pyridin-3-yl derivative or a pharmaceutically acceptable derivatives thereof has the formula (I) wherein: R0 and R1 are independently H, halogen, alkyl, optionally fluorine substituted alkoxy; R2 is H, hydroxyalkyl, S-alkyl, C(O)H, C(O)-alkyl, alkylsulphonyl or optionally fluorine substituted alkyl or alkoxy; and R3 is alkyl or NH2. The compounds are useful for treating a condition, which is mediated by selective inhibition of COX-2.
Patent NZ-512938-A (NZ)
Title: Toggle bolt device
Inventor: GARFIELD NATHANIEL H
IPC: F16B21/00
Filed: 2000-01-31
Abstract: A fixed positionable toggle bolt device for fastening objects to a substrate comprising a metal anchor member having a nut portion and a selectively frangible positioning and holding assembly engaged with the metal member. The assembly comprises two elongated control legs, with the first ends of the control legs being pivotally attached to the metal member. The second ends of the control legs are movably attached to each other by an elongated undercut element interference, with movement of one leg relative to the other, effected by finger tip sliding, causing the metal anchor member to pivot from substantially in line with an insertion aperture in the substrate, to a position parallel to the substrate when the second ends of the control legs are aligned with each other. A positioning collar is engaged with both legs, holding them in place and is movable along the respective lengths of the legs. The legs are arcuate in cross section with a series of axially extending closely spaced rib-like teeth within the arcuate concavity. The collar is adapted to conform to the arcuate concavity together with a step tooth section to provide a one way ratchet with the legs. Once the metal member is positioned behind the substrate and abutted thereto the collar is ratcheted to a snug fit with the substrate and the legs are broken off to thereby fix the anchor in place.
Patent NZ-513475-A (NZ)
Title: Method of forming open mouth zipper gusset bag
Inventor: AUSNIT STEVEN
IPC: B31B19/36
Filed: 2001-08-09
Abstract: A method of forming a gusseted plastic zipper bag.  The zipper profiles are provided intermittently on a carrier web (18), the thickness of which is less than the bag film (14).  The carrier web (18) is attached to the bag film (14) that has windows (16) cut therein that are aligned transversely so that profile-free section of the carrier web covers the windows.  During bag formation the sections of the bag film with windows covered by the carrier web are folded to form gussets.
Patent NZ-514502-A (NZ)
Title: Spiral log separator
Inventor: LINDENBLATT BRUNO
IPC: B27B31/00
Filed: 2001-09-28
Abstract: A log singulator, for separating a mass of logs, uses a set of parallel spiral rolls rotating in unison. The logs fall between the helical flights of the spiral rolls and are pushed along in a direction perpendicular to the spiral rolls.
Patent NZ-516126-A (NZ)
Title: Production of complex carbohydrates
Inventor: APICELLA MICHAEL A
IPC: A61P31/04
Filed: 2000-05-18
Abstract: The specification relates to a transformed Salmonella bacterium for use as a chimeric carbohydrate production cell. The bacteria has, a lipooligosaccharide (LOS) or lipopolysaccaride (LPS) with a core region containing a terminal heptose, a DNA sequence containing an rfe gene and an isolated DNA sequence containing a lipooligosaccaride-synthesis gene G (lsgG) from Haemophilis influenzae where IsgG encodes LsgG. The process for the production of the H. influenzae-specific lipooligosaccaride is also claimed.
Patent NZ-518423-A (NZ)
Title: Composite structural laminate plate construction comprising outer metal layers and intermediate elastomer layer
Inventor: KENNEDY STEPHEN
IPC: B63B3/14
Filed: 2000-11-02
Abstract: A composite structural laminate plate construction comprises two outer metal layers (1, 2), a form (10) between them and an elastomer layer (20) bonded to the outer metal layers (1, 2) and filling the space between them other than that occupied by the form (10). The form may be foam and may be in partial contact with the metal layers (1, 2).
Patent NZ-519535-A (NZ)
Title: Ear piercing systems with hinged hoop earrings
Inventor: REIL VLADIMIR
IPC: A44C7/00
Filed: 2001-10-16
Abstract: A hinged hoop earring when used with an ear piercing system, the hinged hoop earring comprising: a stud hoop (3); a stud post (1) having a free end (9) and a connected end (8); a hinge (4) attached to a first end (8) of the stud hoop (3), the stud post (1) pivotally mounted on the hinge (4) so that the connected end (8) of the stud post (1) is connected to the hinge (4); and a latch (2) attached to a second end of the stud hoop (3), wherein the latch (2) is adapted to receive a part of the stud post (1) that is proximate to the free end (9) of the stud post (1).
Patent NZ-520806-A (NZ)
Title: Liquified gas expansion chiller for drinking glasses
Inventor: NEWMAN BRIAN
IPC: F25D29/00
Filed: 2001-01-16
Abstract: A chilling apparatus (1) for chilling drinking vessels (44) comprising a liquid gas reservoir (3) in fluid communication with a chilling nozzle (4) under the control of a valve (41) controlled by a control unit (6), so that the drinking vessel may be chilled by a metered quantity of liquid gas vaporizing from the chilling nozzle. The reservoir is provided with a vent (36) to prevent a buildup of vaporized liquid gas in the pipework and/or reservoir.
Patent NZ-525903-A (NZ)
Title: Applicator and stimulator device
Inventor: KEMP DONALD JACK
IPC: A61H19/00
Filed: 2001-11-12
Abstract: An applicator and stimulator device comprises a flexible sleeve closed at one end and having a one or more indented cells (2) in its outer wall (1) and adapted to accommodate a human finger within the sleeve. In order to assist application of fluids it may have one or more cells (2) associated with the outer wall (1) containing fluid retained by a seal. The seal opens or ruptures when pressure is applied across the wall (1) or the wall (1) is in contact with an environment that weakens the seal. The sleeve is formed from an elastic material such as natural or a synthetic rubber such as a highly plasticised PVC resin. The cells (2) associated with the outer wall (1) are formed by creating depressions in the wall (1) during moulding of the device. In its unflexed state the body of the sleeve is substantially cylindrical and the cells (2) are preferably formed on a portion of the sleeve surface near to the closed end sustaining and angle of about 90 degrees over the surface measured from the axis of the cylinder. The cells (2) may contain a lubricant, a pharmacologically active compound or a combination of such substances. The preferred pharmacologically active compound is a vasoactive compound such as vasodilator alone or in admixture with one or more adjuvants to ensure consistency and retention when applied to tissue. At least part of the periphery of the open end of the sleeve may carry a sealed channel (5) filled with a lubricant that is released when the seal is ruptured.
Patent NZ-540349-A (NZ)
Title: Medical treatment control system
Inventor: LIM BERNARD C B
IPC: A61M1/02
Filed: 2003-11-26
Abstract: A device for controlling the collection and delivery of materials to a patient, a system for blood processing and a method of controlling the transfer of blood between a subject patient and a blood treatment unit. The device has a dispenser-engaging portion, the dispenser-engaging portion being operable in a release position to receive a materials dispenser when the dispenser is in a materials-containing configuration, the dispenser-engaging portion being operable in a lock condition for locking the dispenser therewith, and access control means for controlling the release and lock positions according to a material transaction condition.